Literature DB >> 26592494

Enalapril and the VEGFA gene: Personalized medicine in hypertension therapy.

Firoj Kumar Sahoo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26592494     DOI： 10.1007/s00228-015-1984-y

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  4 in total

1.  Sample size calculations: basic principles and common pitfalls.

Authors:  Marlies Noordzij; Giovanni Tripepi; Friedo W Dekker; Carmine Zoccali; Michael W Tanck; Kitty J Jager
Journal:  Nephrol Dial Transplant       Date:  2010-01-12       Impact factor: 5.992

2.  Polymorphisms in VEGFA gene affect the antihypertensive responses to enalapril.

Authors:  G H Oliveira-Paula; R Lacchini; V Fontana; P S Silva; C Biagi; Jose E Tanus-Santos
Journal:  Eur J Clin Pharmacol       Date:  2015-05-24       Impact factor: 2.953

Review 3.  The interaction of genetic and environmental factors in the etiology of hypertension.

Authors:  J Kunes; J Zicha
Journal:  Physiol Res       Date:  2009       Impact factor: 1.881

Review 4.  Role of genomics in eliminating health disparities.

Authors:  Meghana V Kashyap; Michael Nolan; Marc Sprouse; Ranajit Chakraborty; Deanna Cross; Rhonda Roby; Jamboor K Vishwanatha
Journal:  J Carcinog       Date:  2015-09-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.